Delivery Order SPE2DB24D2101-SPE2DB25FKPMN
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Insulin Aspart 100 Unit/mL pens (3mL) under a firm fixed-price contract with a ceiling value of $1,865.96. This non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a ceiling value of $9,672.58. This firm fixed price delivery order, which is not associated with a set-aside program, represents a competitive procurement to support federal medical supply needs. The order is scheduled for completion by August 14, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.96 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a firm fixed price structure. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. This delivery order represents a competitive award exercised under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,409.30 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Insulin Aspart 100 Unit/ML cartridges in 3ML quantities. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a straightforward pharmaceutical procurement with no set-aside designation, awarded competitively. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Insulin Aspart 100 Unit/mL vials (10mL) with a ceiling value of $2,262.05. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,463.20 for Insulin Aspart 100 Unit/mL vials (10mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.80 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Insulin Aspart 100 Unit/ml in 10ml vials. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by September 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $4,196.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL vials (10mL) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,490 units of insulin aspart 100 unit/mL pens. The $7,975.68 contract has a completion date of February 6, 2024 and was awarded on February 5, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL vials (10mL) valued at $2,843.25 on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, firm fixed price delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...